Predicted protein targets (top 16)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | CES2 | O00748 | 4/20 | 0.64 |
| ▸ | CES1 | P23141 | 4/20 | 0.64 |
| ▸ | THRB | P10828 | 1/20 | 0.54 |
| ▸ | KMT2A | Q03164 | 2/20 | 0.52 |
| ▸ | TDP1 | Q9NUW8 | 2/20 | 0.48 |
| ▸ | LMNA | P02545 | 1/20 | 0.47 |
| ▸ | MEN1 | O00255 | 1/20 | 0.45 |
| ▸ | BCHE | P06276 | 1/20 | 0.44 |
| ▸ | GAA | P10253 | 1/20 | 0.44 |
| ▸ | POLB | P06746 | 1/20 | 0.43 |
| ▸ | HTT | P42858 | 2/20 | 0.42 |
| ▸ | JAK2 | O60674 | 1/20 | 0.42 |
| ▸ | JAK1 | P23458 | 1/20 | 0.42 |
| ▸ | TYK2 | P29597 | 1/20 | 0.42 |
| ▸ | NOD2 | Q9HC29 | 1/20 | 0.42 |
| ▸ | ALB | P02768 | 1/20 | 0.41 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL12160758 | 0.86 | CES2 (0.54) | CES2CES1THRBKMT2ATDP1 | |
| SCHEMBL467416 | 0.86 | THRB (0.71) | CES2CES1THRBKMT2ATDP1 | |
| SCHEMBL30116840 | 0.84 | CES2 (0.52) | CES2CES1THRBKMT2ATDP1 | |
| SCHEMBL14416609 | 0.84 | CES2 (0.52) | CES2CES1THRBKMT2ATDP1 | |
| SCHEMBL13040776 | 0.84 | CES2 (0.52) | CES2CES1THRBKMT2ATDP1 | |
| SCHEMBL14454258 | 0.84 | CES2 (0.52) | CES2CES1THRBKMT2ATDP1 | |
| SCHEMBL29443043 | 0.84 | GAA (0.54) | CES2CES1KMT2ALMNAMEN1 | |
| SCHEMBL716550 | 0.84 | GAA (0.54) | CES2CES1KMT2ALMNAMEN1 | |
| SCHEMBL4119544 | 0.84 | CES2 (0.52) | CES2CES1THRBKMT2ATDP1 | |
| SCHEMBL1957640 | 0.81 | CA9 (0.57) | CES2CES1THRBKMT2ALMNA |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 690 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| CN-119926191-B | Conjugated microporous organic solvent-resistant nanofiltration composite membrane and preparation method and application thereof | 中山大学 | 2025-06-13 | — | — | CN | claimed |
| CN-119926191-A | Conjugated microporous organic solvent-resistant nanofiltration composite membrane and preparation method and application thereof | 中山大学 | 2025-05-06 | — | — | CN | claimed |
| CN-119859094-A | Preparation method of 2, 6-dihydroxyacetophenone | 湖南卢普药业有限公司 | 2025-04-22 | — | — | CN | claimed |
| CN-118459422-A | Thiazole thiazolinone compound containing multiple halogen atoms and preparation method thereof | 南京工业大学 | 2024-08-09 | — | — | CN | claimed |
| CN-118459420-A | Thiazolinone compound containing multiple halogen atoms and preparation method thereof | 南京工业大学 | 2024-08-09 | — | — | CN | claimed |
| CN-114950159-B | Preparation method of aromatic polymer separation membrane based on super acid catalysis | 南京工业大学 | 2023-06-06 | — | — | CN | claimed |
| CN-116041212-A | Preparation and application of difluoro olefin ether and oxime ether derivatives | 安徽农业大学 | 2023-05-02 | — | — | CN | claimed |
| CN-114950159-A | Preparation method of aromatic polymer separation membrane based on super-acid catalysis preparation | 南京工业大学 | 2022-08-30 | — | — | CN | claimed |
| CN-112608277-B | Fluorine-containing quinoline ester compound and preparation method and application thereof | 浙江工业大学 | 2022-08-05 | — | — | CN | claimed |
| CN-113135590-B | Preparation method of perovskite nanorod | 南京邮电大学 | 2022-04-01 | — | — | CN | claimed |
| CN-113233498-A | Method for adjusting perovskite luminescence wavelength by fluoride | 南京邮电大学 | 2021-08-10 | — | — | CN | claimed |
| CN-113135590-A | Preparation method of perovskite nanorod | 南京邮电大学 | 2021-07-20 | — | — | CN | claimed |
| CN-112608277-A | Fluorine-containing quinoline ester compound and preparation method and application thereof | 浙江工业大学 | 2021-04-06 | — | — | CN | claimed |
| US-9174906-B2 | Process for producing optically active secondary alcohol | KANTO KAGAKU KABUSHIKI KAISHA (JP) | 2015-11-03 | — | — | US | claimed |
| US-8952083-B2 | Fluorocopolymer composition and its production process | ASAHI GLASS COMPANY, LIMITED (JP) | 2015-02-10 | — | — | US | claimed |
| JP-4711621-B2 | — | — | 2011-06-29 | — | — | JP | claimed |
| US-20050256333-A1 | Compounds for the treatment of metabolic disorders | WELLSTAT THERAPEUTICS CORPORATION | 2005-11-17 | — | — | US | claimed |
| EP-1461323-A2 | COMPOUNDS FOR THE TREATMENT OF METABOLIC DISORDERS | Wellstat Therapeutics Corporation (US) | 2004-09-29 | — | — | EP | claimed |
| WO-2002100341-A2 | COMPOUNDS FOR THE TREATMENT OF METABOLIC DISORDERS | WELLSTAT THERAPEUTICS CORPORATION (US) | 2002-12-19 | — | — | WO | claimed |
| EP-0660832-B1 | SEROTONIN RECEPTOR AGENTS | MERRELL PHARMA INC (US) | 1998-01-14 | — | — | EP | claimed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20050256333-A1 | Compounds for the treatment of metabolic disorders | GOT2, OAT, CPT1B | CES2 425/4885CES1 45/4885THRB 333/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.